AbbVie Profit Margin 2010-2018 | ABBV

Current and historical gross margin, operating margin and net profit margin for AbbVie (ABBV) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. AbbVie net profit margin as of June 30, 2018 is 20.84%.
AbbVie Annual Profit Margins
AbbVie Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $139.177B $28.216B
AbbVie is a global, research-based biopharmaceutical company. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie aims to help patients' live healthier lives and collaborate on sustainable healthcare solutions.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $366.377B 17.18
Pfizer (PFE) United States $261.509B 15.31
Novartis AG (NVS) Switzerland $198.652B 17.04
Merck (MRK) United States $192.023B 16.96
Eli Lilly (LLY) United States $119.245B 22.07
Sanofi (SNY) France $111.234B 14.08
Novo Nordisk (NVO) Denmark $106.025B 16.95
AstraZeneca (AZN) United Kingdom $98.986B 10.89
GlaxoSmithKline (GSK) United Kingdom $98.701B 13.18
Bristol-Myers Squibb (BMY) United States $94.525B 17.11